A similar observation was reported by Kottaridis et al. (39) who found more than one mutation in 23% of FLT3–ITD AML patients, with up to five different FLT3–ITD clones of various sizes, insertion sites, and ARs identified. Here, FLT3 is linked to acute myeloid leukemia.